Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
Clinical trial NCT06940518 · RECRUITING
Trial details
- NCT number
- NCT06940518
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2028-01-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.